JACOBS LEVY EQUITY MANAGEMENT, INC

Position in WGS — GeneDx Holdings Corp.

CIK 884414 FLORHAM PARK, NJ

Position in WGS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$959,703

+$96,105 QoQ

Shares Held

14,944

+125.1% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $62,344,672 across 9 Diagnostics & Research names. WGS ranks #8 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CDNA	CareDx, Inc.	864,468	$15,007,164
2	NTRA	Natera, Inc.	69,767	$13,952,702
3	DHR	Danaher Corp /De/	68,743	$13,033,672
4	MYGN	Myriad Genetics Inc	2,088,492	$9,398,214
5	FLGT	Fulgent Genetics, Inc.	356,359	$5,666,108
6	GRAL	GRAIL, Inc.	34,837	$1,800,376
7	GH	Guardant Health, Inc.	17,357	$1,603,266
8	WGS	GeneDx Holdings Corp. This page	14,944	$959,703

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$959,703	14,944	+125.1%	Shares	Sole	2026-05-15
2025-12-31	$863,598	6,640	-3.0%	Shares	Sole	2026-02-13
2025-09-30	$737,264	6,843	-45.1%	Shares	Sole	2025-11-17
2025-06-30	$1,150,644	12,465	+126.2%	Shares	Sole	2025-08-14
2025-03-31	$488,081	5,511	-91.9%	Shares	Sole	2025-05-15
2024-09-30	$2,876,413	67,776	-66.5%	Shares	Sole	2024-11-14
2024-06-30	$5,281,926	202,063	0.0%	Shares	Sole	2024-08-14
2024-03-31	$1,844,835	202,063	-35.6%	Shares	Sole	2024-05-15
2023-12-31	$862,562	313,659	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.